SQZ Biotechnologies Company
SQZ was delisted on the 3rd of July, 2023.
36 hedge funds and large institutions have $234M invested in SQZ Biotechnologies Company in 2020 Q4 according to their latest regulatory filings, with 36 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Temasek Holdings
Singapore
|
+$64.2M |
| 2 |
AG
Artal Group
Luxembourg
|
+$41M |
| 3 |
MC
Maverick Capital
Dallas,
Texas
|
+$23.9M |
| 4 |
AI
Alphabet Inc
Mountain View,
California
|
+$21.2M |
| 5 |
BM
Bridger Management
New York
|
+$20.6M |
Top Sellers
SQZ Hedge Fund Activity: Q4 2020 in Review
36 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in SQZ Biotechnologies Company (SQZ) for Q4 2020, worth a combined $234M.
Buyers outnumbered sellers: 36 funds opened new SQZ positions and 0 closed out — a net gain of 36 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Temasek Holdings, opening a new position worth an estimated $64.2M.
- 36 institutional investors held SQZ Biotechnologies Company (SQZ) as of Q4 2020, up from 0 in Q3 2020.
- Funds reported $234M of SQZ Biotechnologies Company stock for Q4 2020.
- 36 funds opened new SQZ Biotechnologies Company positions in Q4 2020 and 0 closed out, a net change of +36 holders.
- The largest SQZ Biotechnologies Company buyer in Q4 2020 was Temasek Holdings, an estimated $64.2M added.
Based on aggregated 13F filings for Q4 2020.